+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Delta Agonist"

PPAR-Beta / Delta Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

PPAR-Beta / Delta Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Delta agonists are a class of drugs used to treat conditions related to the central nervous system. They act on delta receptors, which are found in the brain and spinal cord, and are involved in the regulation of pain, anxiety, and other neurological processes. Delta agonists are used to treat a variety of conditions, including epilepsy, anxiety, depression, and chronic pain. They are also used to treat drug addiction, as they can reduce the craving for drugs and reduce the risk of relapse. Delta agonists are typically administered orally, intravenously, or intramuscularly. They are generally well-tolerated, with few side effects. Common side effects include drowsiness, dizziness, and nausea. The delta agonist market is a rapidly growing segment of the central nervous system drug market. It is expected to continue to grow in the coming years, driven by the increasing prevalence of neurological disorders and the growing demand for effective treatments. Some companies in the delta agonist market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more